http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2629213-C1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4cc81c2c7423144bfbb39c9cdfdb4361
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B3-00
filingDate 2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e47fe8f9b9797647918f9300e28c51a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_79e4b7fc06c1ab9f7f66f6cde506379a
publicationDate 2017-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2629213-C1
titleOfInvention Method for determination of primary open angle glaucoma stage based on state of biomechanical properties of tunica fibrosa oculi
abstract FIELD: medicine. n SUBSTANCE: biomechanical parameters of the tunica fibrosa oculi are studied before and after discharge testing. The ratio of change in the corneal hysteresis (ΔCH) to a change in the cornea resistance factor (ΔCRF) is calculated by the formula ΔCH/ΔCRF, where ΔCH is the difference of corneal hysteresis before and after the test, ΔCRF is the difference of cornea resistance factor before and after the test. At ΔCH/ΔCRF of 0.91-1.49, the norm is determined, at ΔCH/ΔCRF of 1.5-1.99, the first stage of POAG, 2.00-3.2 - the second stage of POAG, 0.9 and less - the third stage of POAG is determined. n EFFECT: increased accuracy of determination of the primary open angle glaucoma stage with an ability to identify the intermediate steps in the transition from the current stage of primary open angle glaucoma to the next one and adequate prediction of the disease. n 2 ex
priorityDate 2016-07-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5311221
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54670067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454672121
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9868491
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11387895
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419474822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451582911
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46878360
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419483452

Total number of triples: 25.